Dr Regueiro, chief of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation at the Advances in Inflammatory Bowel Diseases regional meeting on positioning and sequencing therapies for Crohn disease and...
Dr Regueiro, chief of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation at the Advances in Inflammatory Bowel Diseases regional meeting on positioning and sequencing therapies for Crohn disease and...
Dr Strong, from Northwestern Medicine in Chicago, reviews the key points of his lecture on the need for a team approach to perianal Crohn disease from the July 23 AIBD conference.
Dr Strong, from Northwestern Medicine in Chicago, reviews the key points of his lecture on the need for a team approach to perianal Crohn disease from the July 23 AIBD conference.
Dr Charabaty reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting in Chicago on helping patients plan for conception, choose the right medications, and ensure a healthy mom and baby.
Dr Charabaty reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting in Chicago on helping patients plan for conception, choose the right medications, and ensure a healthy mom and baby.
Dr Cohen discusses his talk on managing infections such as cytomegalovirus and histoplasmosis among patients with IBD, and testing for tuberculosis before starting immunosuppressive therapy.
Dr Cohen discusses his talk on managing infections such as cytomegalovirus and histoplasmosis among patients with IBD, and testing for tuberculosis before starting immunosuppressive therapy.
Dr Rubin, from the University of Chicago, discusses how using a treat to target approach can enhance patient quality of life, achieve tight control of inflammatory bowel disease, and ensure optimal outcomes.
Dr Rubin, from the University of Chicago, discusses how using a treat to target approach can enhance patient quality of life, achieve tight control of inflammatory bowel disease, and ensure optimal outcomes.
Dr Charabaty, from Johns Hopkins University School of Medicine, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting in Chicago on the key steps for managing the patient with acute severe ulcerative...
Dr Charabaty, from Johns Hopkins University School of Medicine, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting in Chicago on the key steps for managing the patient with acute severe ulcerative...
Dr Regueiro, from Cleveland Clinic and chair of the AIBD regional meeting in Chicago, provides an overview of the faculty and topics that will be featured.
Dr Regueiro, from Cleveland Clinic and chair of the AIBD regional meeting in Chicago, provides an overview of the faculty and topics that will be featured.
Dr Horst, from Vanderbilt University Medical Center, reviews the key points of her presentation from Digestive Disease Week 2022 on treatment options for patients with ulcerative colitis for whom multiple biologic treatments have failed.
Dr Horst, from Vanderbilt University Medical Center, reviews the key points of her presentation from Digestive Disease Week 2022 on treatment options for patients with ulcerative colitis for whom multiple biologic treatments have failed.
Dr Dubinsky, from the Icahn School of Medicine at Mount Sinai, gives a preview of the topics and faculty for the Advances in Inflammatory Bowel Disease regional meeting in Boston on June 11.
Dr Dubinsky, from the Icahn School of Medicine at Mount Sinai, gives a preview of the topics and faculty for the Advances in Inflammatory Bowel Disease regional meeting in Boston on June 11.
Dr Higgins gives a recap of his poster presentation at Digestive Disease Week 2022 on evaluating the impact of baseline ulcerative colitis characteristics on clinical outcomes following treatment with upadacitinib.
Dr Higgins gives a recap of his poster presentation at Digestive Disease Week 2022 on evaluating the impact of baseline ulcerative colitis characteristics on clinical outcomes following treatment with upadacitinib.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...